Correlative Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/ Refractory (r/r) ALL Alan Daniel Macias,Karamjeet Sandhu,Marissa M. Del Real,Kim Young, Asucena L. Beltran,Kenneth Ng,Jianying Zhang,Joycelynne Palmer,Marjorie Robbins, James O'Hearn,Mojtaba Akhtari,Guido Marcucci,Lihua E. BuddeMOLECULAR THERAPY(2023)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要